The FluPRINT dataset, a multidimensional analysis of the influenza vaccine imprint on the immune system.


Journal

Scientific data
ISSN: 2052-4463
Titre abrégé: Sci Data
Pays: England
ID NLM: 101640192

Informations de publication

Date de publication:
21 10 2019
Historique:
received: 07 02 2019
accepted: 27 08 2019
entrez: 23 10 2019
pubmed: 23 10 2019
medline: 8 10 2020
Statut: epublish

Résumé

Machine learning has the potential to identify novel biological factors underlying successful antibody responses to influenza vaccines. The first attempts have revealed a high level of complexity in establishing influenza immunity, and many different cellular and molecular components are involved. Of note is that the previously identified correlates of protection fail to account for the majority of individual responses across different age groups and influenza seasons. Challenges remain from the small sample sizes in most studies and from often limited data sets, such as transcriptomic data. Here we report the creation of a unified database, FluPRINT, to enable large-scale studies exploring the cellular and molecular underpinnings of successful antibody responses to influenza vaccines. Over 3,000 parameters were considered, including serological responses to influenza strains, serum cytokines, cell phenotypes, and cytokine stimulations. FluPRINT, facilitates the application of machine learning algorithms for data mining. The data are publicly available and represent a resource to uncover new markers and mechanisms that are important for influenza vaccine immunogenicity.

Identifiants

pubmed: 31636302
doi: 10.1038/s41597-019-0213-4
pii: 10.1038/s41597-019-0213-4
pmc: PMC6803714
doi:

Substances chimiques

Cytokines 0
Influenza Vaccines 0

Types de publication

Dataset Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

214

Subventions

Organisme : NCRR NIH HHS
ID : UL1 RR025744
Pays : United States
Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : FluPRINT, No 796636
Pays : International
Organisme : NIAID NIH HHS
ID : U19 AI090019
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003142
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI057229
Pays : United States

Références

Nat Immunol. 2016 Feb;17(2):204-13
pubmed: 26726811
J Immunol. 2014 Jan 15;192(2):603-11
pubmed: 24337376
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Immunity. 2015 Dec 15;43(6):1186-98
pubmed: 26682988
PLoS One. 2013 May 29;8(5):e64555
pubmed: 23734205
Nat Immunol. 2014 Feb;15(2):128-35
pubmed: 24448570
J Infect Dis. 2016 Dec 1;214(11):1666-1671
pubmed: 27655870
Bio Protoc. 2015;5(2):
pubmed: 27390767
Nat Immunol. 2011 Jul 10;12(8):786-95
pubmed: 21743478
J Allergy Clin Immunol. 2016 Feb;137(2):579-586.e7
pubmed: 26309181
Cell. 2014 Apr 10;157(2):499-513
pubmed: 24725414
Nat Commun. 2016 Mar 23;7:11112
pubmed: 27005435
J Exp Med. 1942 Jan 1;75(1):49-64
pubmed: 19871167
Cell. 2015 Jan 15;160(1-2):37-47
pubmed: 25594173
Sci Transl Med. 2013 Mar 13;5(176):176ra32
pubmed: 23486778
Cell Host Microbe. 2014 Jul 9;16(1):105-14
pubmed: 24981332
Cell Rep. 2016 Feb 9;14(5):1218-1231
pubmed: 26832412
J Infect Dis. 2015 Sep 15;212(6):861-70
pubmed: 25740957
Nat Med. 2017 Feb;23(2):174-184
pubmed: 28092664
Sci Transl Med. 2013 Oct 23;5(208):208ra145
pubmed: 24154599
J Infect Dis. 2017 Mar 1;215(5):740-749
pubmed: 28007925
J Clin Invest. 2011 Aug;121(8):3109-19
pubmed: 21785218
Nat Med. 2018 Feb;24(2):144-153
pubmed: 29309059
Bio Protoc. 2015 Jun 5;5(11):
pubmed: 27135045
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):869-74
pubmed: 24367114
Vaccine. 2014 Oct 14;32(45):5989-97
pubmed: 25203448
PLoS One. 2015 Jul 21;10(7):e0133627
pubmed: 26197454
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1853-8
pubmed: 26755593
Clin Infect Dis. 2012 May;54(10):1427-36
pubmed: 22495079
Mol Syst Biol. 2013 Apr 16;9:659
pubmed: 23591775
J Infect Dis. 2015 Apr 1;211(7):1051-9
pubmed: 25336731
J Immunol Methods. 2011 Feb 28;365(1-2):67-75
pubmed: 21182843
Nat Med. 2013 Oct;19(10):1305-12
pubmed: 24056771
Curr Opin Immunol. 2018 Apr;51:187-196
pubmed: 29655022
J Vis Exp. 2012 Nov 02;(69):e4398
pubmed: 23149654
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13463-8
pubmed: 23898164
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1105-1110
pubmed: 28096374
Nat Med. 2019 Mar;25(3):487-495
pubmed: 30842675
Autoimmunity. 2015;48(8):513-23
pubmed: 26333287
Dev Biol (Basel). 2003;115:63-73
pubmed: 15088777
J Infect Dis. 2013 Jan 15;207(2):288-96
pubmed: 23107783
Sci Data. 2018 Feb 27;5:180015
pubmed: 29485622
Sci Immunol. 2017 Sep 29;2(15):
pubmed: 28963118
Trends Immunol. 2012 Jul;33(7):323-32
pubmed: 22476049
Immunity. 2012 Jan 27;36(1):142-52
pubmed: 22265676
Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14506-11
pubmed: 25246558
Bio Protoc. 2015 Jun 5;5(11):
pubmed: 27446979
Sci Transl Med. 2013 Feb 6;5(171):171ra19
pubmed: 23390249
Cell. 2018 May 31;173(6):1385-1397.e14
pubmed: 29706550
Vaccine. 2015 Sep 29;33(40):5294-301
pubmed: 25858860
Cell Syst. 2016 Oct 26;3(4):374-384.e4
pubmed: 27746093
Eur J Immunol. 2019 Feb;49(2):212-220
pubmed: 30653669
Sci Transl Med. 2015 Apr 1;7(281):281ra43
pubmed: 25834109
Sci Transl Med. 2015 Aug 26;7(302):302ra135
pubmed: 26311730
J Transl Med. 2012 Mar 28;10:62
pubmed: 22452993
Elife. 2016 Aug 02;5:
pubmed: 27481325

Auteurs

Adriana Tomic (A)

Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, 94304, USA. info@adrianatomic.com.
Oxford Vaccine Group, Department of Pediatrics, University of Oxford, Oxford, OX3 9DU, UK. info@adrianatomic.com.

Ivan Tomic (I)

Independent Researcher, Stanford, USA.

Cornelia L Dekker (CL)

Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, 94304, USA.

Holden T Maecker (HT)

Human Immune Monitoring Center, Stanford University, Stanford, CA, 94304, USA.

Mark M Davis (MM)

Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, 94304, USA. mmdavis@stanford.edu.
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, 94304, USA. mmdavis@stanford.edu.
Howard Hughes Medical Institute, Stanford University, Stanford, CA, 94304, USA. mmdavis@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH